Details for New Drug Application (NDA): 215457
✉ Email this page to a colleague
The generic ingredient in NALOXONE HYDROCHLORIDE (AUTOINJECTOR) is naloxone hydrochloride. There are twelve drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.
Summary for 215457
Tradename: | NALOXONE HYDROCHLORIDE (AUTOINJECTOR) |
Applicant: | Kaleo Inc |
Ingredient: | naloxone hydrochloride |
Patents: | 18 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 215457
Mechanism of Action | Opioid Antagonists |
Medical Subject Heading (MeSH) Categories for 215457
Suppliers and Packaging for NDA: 215457
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NALOXONE HYDROCHLORIDE (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 215457 | NDA | Kaleo, Inc. | 60842-002 | 60842-002-02 | 10 DOSE PACK in 1 CARTON (60842-002-02) / .4 mL in 1 DOSE PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | Strength | 10MG/0.4ML (10MG/0.4ML) | ||||
Approval Date: | Feb 28, 2022 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Try a Trial | Patent Expiration: | May 24, 2031 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | USE OF A DELIVERY DEVICE TO DELIVER A DOSE OF NALOXONE | ||||||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Nov 23, 2024 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Try a Trial | Patent Expiration: | Feb 28, 2031 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE |
Complete Access Available with Subscription